RSSS stock news
This page provides real-time market news, earnings updates, and company announcements related to Research Solutions, Inc (RSSS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-24 07:31 EST
Diminishing Optimists in the Stock Market Find Encouragement Amid Growing Gloom
101 finance2026-02-24 11:12:37
Henry Schein: Fourth Quarter Earnings Overview
101 finance2026-02-24 11:21:44
Armstrong World Industries: Fourth Quarter Financial Overview
101 finance2026-02-24 11:21:44
Home Depot: Overview of Fourth Quarter Financial Results
101 finance2026-02-24 11:21:43
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common stock.
老虎证券2026-02-24 11:24:06
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common stock.
老虎证券2026-02-24 11:24:07
Investors Are Selling Off Software Shares and Strong Earnings Won’t Change That
101 finance2026-02-24 11:36:44
CECO: Fourth Quarter Earnings Overview
101 finance2026-02-24 11:48:43
Planet Fitness: Fourth Quarter Financial Highlights
101 finance2026-02-24 11:48:44
Westlake: Fourth Quarter Earnings Overview
101 finance2026-02-24 11:57:39
Chevron (CVX)'s the Only Company I Would Buy Here, Says Jim Cramer
Finviz2026-02-24 12:00:16
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-24 12:03:56
Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:56
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Finviz2026-02-24 12:03:59
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
Dillard's: Overview of Fourth Quarter Financial Results
101 finance2026-02-24 12:18:34
Iovance Biotherapeutics recently announced plans to launch a single-arm registration clinical trial in the second quarter of 2026.
老虎证券2026-02-24 12:23:04
Skittish investors spooked as dystopian AI outlooks go viral
101 finance2026-02-24 12:27:16
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common stock.
老虎证券2026-02-24 11:24:06
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common stock.
老虎证券2026-02-24 11:24:07
Investors Are Selling Off Software Shares and Strong Earnings Won’t Change That
101 finance2026-02-24 11:36:44
CECO: Fourth Quarter Earnings Overview
101 finance2026-02-24 11:48:43
Planet Fitness: Fourth Quarter Financial Highlights
101 finance2026-02-24 11:48:44
Westlake: Fourth Quarter Earnings Overview
101 finance2026-02-24 11:57:39
Chevron (CVX)'s the Only Company I Would Buy Here, Says Jim Cramer
Finviz2026-02-24 12:00:16
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-24 12:03:56
Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:56
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Finviz2026-02-24 12:03:59
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
Dillard's: Overview of Fourth Quarter Financial Results
101 finance2026-02-24 12:18:34
Iovance Biotherapeutics recently announced plans to launch a single-arm registration clinical trial in the second quarter of 2026.
老虎证券2026-02-24 12:23:04
Skittish investors spooked as dystopian AI outlooks go viral
101 finance2026-02-24 12:27:16
RSSS stock chart
RSSS stock detailsRSSS stock price change
On the last trading day, RSSS stock closed at 2.50 USD, with a price change of -0.40% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more